NASDAQ
Noxopharm Limited (NOXOF) has a free cash flow growth of -232.01% as of Friday, May 29, 2026. This represents a 197.58% decrease compared to its 12-month average of -77.96%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.